Tae Heum Jeong
2016
In 2016, Tae Heum Jeong earned a total compensation of $393.6K as Chief Financial Officer at Rexahn Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $61,950 |
|---|---|
| Option Awards | $22,958 |
| Salary | $295,000 |
| Other | $13,736 |
| Total | $393,644 |
Jeong received $295K in salary, accounting for 75% of the total pay in 2016.
Jeong also received $62K in non-equity incentive plan, $23K in option awards and $13.7K in other compensation.
Rankings
In 2016, Tae Heum Jeong's compensation ranked 11,979th out of 14,075 executives tracked by ExecPay. In other words, Jeong earned more than 14.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,979 out of 14,075 | 15th |
Division Manufacturing | 4,693 out of 5,489 | 15th |
Major group Chemicals And Allied Products | 1,678 out of 1,895 | 12th |
Industry group Drugs | 1,362 out of 1,538 | 11th |
Industry Pharmaceutical Preparations | 1,053 out of 1,176 | 11th |
Source: SEC filing on February 24, 2017.
Jeong's colleagues
We found three more compensation records of executives who worked with Tae Heum Jeong at Rexahn Pharmaceuticals in 2016.